In cancers such as acute myeloid leukemia, cells exhibit a critical addiction to the vitamin B6 metabolic pathway, selectively upregulating Pyridoxal Kinase (PDXK) to produce high levels of PLP. This evidence concerns the gene PDXK and cancer.